A Comparative Analysis: Selenium Sulfide vs Ketoconazole in Seborrheic Dermatitis and Dandruff Dr. Kamal Kant Kohli9 Dec 2024 9:15 AM ISTSeborrheic dermatitis is a prevalent inflammatory skin condition characterized by papulosquamous lesions, primarily affecting areas abundant in...
Combatting Anti-fungal Resistance: Selenium Sulfide as a Promising Solution in Tackling Tinea Versicolor and Seborrheic Dermatitis Dr. Kamal Kant Kohli13 Nov 2024 12:33 PM ISTIn the world of microbes, the evolution of resistance to antimicrobial drugs is a process that is nearly inevitable. (1) While fungal resistance is...
The Potential Additive Benefits of the Combination of Selenium Sulfide and Salicylic Acid in Dandruff and Seborrheic Dermatitis Treatment Dr. Kamal Kant Kohli9 Sept 2024 11:30 AM ISTIntroductionSeborrheic dermatitis is characterized by red scaly lesions primarily spread across the scalp, face, upper trunk, nasolabial folds,...
Factors Affecting Compliance in Patients with Seborrheic Dermatitis: The Role of Texture, Fragrance, and Packaging Dr. Kamal Kant Kohli1 Aug 2024 11:30 AM ISTIntroduction:Patient adherence is crucial for therapeutic success, since non-compliance can affect treatment outcomes in certain dermatological...
From Mystery to Management: The Ongoing Story of Seborrheic Dermatitis Dr. Kamal Kant Kohli27 Jun 2024 12:45 PM ISTIntroduction - First identified in 1887, seborrheic dermatitis (SD) still remains an enigma. [1]It is a common skin condition frequently linked to...
Roflumilast Foam Potential Game-Changer in Seborrheic Dermatitis Treatment Dr.Niharika Harsha B4 Feb 2024 10:00 PM ISTIn a remarkable breakthrough, a novel topical treatment has demonstrated unprecedented efficacy in tackling seborrheic dermatitis (SD), a chronic skin...
Roflumilast topical foam receives FDA approval for treating seborrheic dermatitis Dr. Kamal Kant Kohli18 Dec 2023 8:00 AM ISTUSA: Roflumilast topical foam, 0.3% has received approval from the US Food and Drug Administration (FDA), for the treatment of seborrheic dermatitis...
Oral isotretinoin promising for treatment of moderate to severe seborrheic dermatitis Dr. Kamal Kant Kohli4 Aug 2023 10:15 AM ISTCanada: Seborrheic dermatitis (SD) is a chronic inflammatory skin condition characterized by redness and scaling, often affecting areas with higher...
Roflumilast Foam Found Safe and Effective for Seborrheic Dermatitis Treatment: JAMA Dr. Mahalakshmi Sivashankaran12 May 2023 10:00 AM ISTA recent clinical trial published in JAMA: Dermatology has shown promising results for roflumilast foam as a nonsteroidal topical treatment option for...
Roflumilast foam useful in patients with moderate to severe seborrheic dermatitis, reveals phase 3 trial Dr. Kamal Kant Kohli12 Jun 2022 7:30 PM ISTWESTLAKE VILLAGE, Calif: Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful...
Seborrheic dermatitis linked to metabolic syndrome, suggests study Medha Baranwal31 May 2022 8:00 PM ISTTurkey: Seborrheic Dermatitis (SD) can be considered a marker of metabolic syndrome (MetS) and its presence should be examined in these patients,...
Seborrheic Dermatitis associated with Insulin Resistance: Study Dr. Shravani Dali22 Nov 2021 9:00 AM ISTSeborrheic Dermatitis associated with Insulin Resistance, suggests a study published in the Metabolic Syndrome and Related Disorders Our knowledge...
